# OSPREY PHARMACEUTICALS USA INC — Form D

OSPREY PHARMACEUTICALS USA INC of San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-20. The offering totals $9.0M, of which $5.9M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2009-05-20
- Form: D
- Accession: 0001436994-09-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $9.0M
- Amount sold: $5.9M
- Remaining: $3.2M
- Investors: 5
- Date of first sale: 2009-05-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-118943

## Issuer

- Name: OSPREY PHARMACEUTICALS USA INC
- CIK: 0001436994
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2008
- Address: 425 California Street, San Francisco, CA, 94104
- Phone: 415-362-6262

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Jack Anthony | Director | San Francisco, CA |
| John Hamer | Director | Durham, NC |
| Martial LaCroix | Director | Montreal, A8 |
| Jean-Francois Pariseau | Director | Mississauga, A6 |
| NASSIM USMAN | Director | South San Francisco, CA |
| Jack Anthony | Executive Officer | San Francisco, CA |
| Barbara Finck | Executive Officer | San Francisco, CA |

## More

- [CIK 1436994 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1436994&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001436994-09-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.